# Evaluation of Atacand® (Candesartan) in Daily Medical Practice

> **NCT00837720** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 750 (actual)

## Conditions studied

- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00837720
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2009-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837720, "Evaluation of Atacand® (Candesartan) in Daily Medical Practice". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00837720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*